Fruquintinib Combined With Adebrelimab and High and Low Dose Radiotherapy in the Treatment of Second-line and Above Failure MSS Metastatic Colorectal Cancer.
- Status
- RECRUITING
- Phase
- NA
Clinical Trials Related to Fruquintinib
Related studies linked through entity extraction aliases.
Study of Fruquintinib Plus Sintilimab for Treatment of Advanced Endometrial Cancer
- Status
- RECRUITING
- Phase
- PHASE3
A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer
- Status
- RECRUITING
- Phase
- PHASE4
Cadonilimab Combined With Fruquintinib and SBRT as Athird-line and Posterior Line Treatment in Patients With MSS CRC
- Status
- RECRUITING
- Phase
- NA
ctDNA-guided Treatment of TKI Plus PD-1 Inhibitor for Advanced pMMR/MSS Colorectal Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Tucidinostat in Combination With Sintilimab and Bevacizumab in MSS/pMMR Colorectal Cancer Patients
- Status
- RECRUITING
- Phase
- PHASE3
Fruquintinib and Pirfenidone in Combination With Anti-PD-1 Antibody in Advanced or Metastatic pMMR/MSS Colorectal Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Fruquintinib After ICIs Treatment in Unresectable Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
Fruquintinib With or Without HAI-FOLFOX for Refractory Colorectal Cancer
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
Fruquintinib Plus S-1 and Raltitrexed (RSF) for MCRC
- Status
- RECRUITING
- Phase
- PHASE2
Fruquintinib and Albumin-paclitaxel Combined With or Without PD-1 Antibody in 2nd-line Treatment of G/GEJ Adenocarcinoma
- Status
- RECRUITING
- Phase
- N/A
Oral Inulin in Combination With Fruquintinib Plus Sintilimab as Third- or Further-line Treatment in Metastatic Colorectal Cancer
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
A Phase II Clinical Study of the Efficacy and Safety of Tislelizumab Combined With Fruquintinib and Chidamide in the Treatment of Unresectable or Advanced Microsatellite Stabilized (MSS/pMMR) Colorectal Cancer With Liver Metastases
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Fruquintinib-based Treatment for Refractory Bone and Soft Tissue Sarcomas After Several Lines of TKIs' Resistance
- Status
- COMPLETED
- Phase
- N/A
Fruquintinib in Refractory Metastatic Colorectal Cancer: A Real-world Study
- Status
- COMPLETED
- Phase
- N/A
Cadonilimab Combined With Fruquintinib and SBRT as Athird-line and Posterior Line Treatment in Patients With MSS CRC
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Study of Fruquintinib Combined With Raltitrexed in the Treatment of Metastatic Colorectal Cancer
- Status
- RECRUITING
- Phase
- PHASE4
Clinical Study of Fruquintinib Combined With Sintilimab and XELOX Regimen in the Treatment of Advanced Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Fruquintinib With PD-1 Inhibitors Versus TAS-102 With Bevacizumab in Late-Line mCRC
- Status
- COMPLETED
- Phase
- N/A
Efficacy of Modified Fruquintinib in Colorectal Cancer Liver Metastases: A Phase II Study
- Status
- RECRUITING
- Phase
- PHASE2